Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), PROGNÓSTICO, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPENCER, S. K. M. et al. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, v. 109, n. 11, p. 2765-2773, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.649. Acesso em: 20 maio 2024.APA
Spencer, S. K. M., Pommier, A. J. C., Morgan, S. R., Barry, S. T., Robertson, J. D., Hoff, P. M., & Jürgensmeier, J. M. (2013). Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, 109( 11), 2765-2773. doi:10.1038/bjc.2013.649NLM
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 maio 20 ] Available from: https://doi.org/10.1038/bjc.2013.649Vancouver
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2024 maio 20 ] Available from: https://doi.org/10.1038/bjc.2013.649